Approved Study Database

Ref. No. Scientific Title Principal investigator
2009.381 Prevention of recurrent idiopathic gastroduoden ulcer bleeding: a double-blind randomized trial Dr. WONG Grace Lai Hung
2009.378 Surgical mask revisited: A prospective randomized crossover study to find out whether wearing surgical mask will affect the efficiency of supplemental oxygen delivery Dr Yip Hing Wah
2009.376 A Randomized, Double-blind, Multi-centre Phase III Study of Brivanib versus Sorafenib as First-line Treatment in Patients with Advanced Hepatocellular Carcinoma: The BRISK FL Study Professor Yeo Winnie
2009.373 Evaluation of self-collected HPV DNA sampling in a Female Sex Workers (FSWs) women Prof. Wong Lai Yi, Eliza
2009.360 A randomised Phase III clinical study of bevacizumab plus capecitabine vs. bevacizumab alone as maintenance therapy in patients with HER2-negative metastatic breast cancer that has not progressed during first-line docetaxel plus bevacizumab therapy Prof. YEO Winnie
2009.355 The Effect of Neutral Peritoneal Dialysis Solution With Minimal Glucose-Degradation-Product on the Fluid Status and Body Composition Prof. SZETO Cheuk Chun
2009.354 A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection Dr Hui Aric Josun
2009.353 A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on generalized anxiety disorder and health service utilization in primary care Dr Wong Samuel Yeung Shan
2009.347 Single-incision (SILA) versus three-port laparoscopic appendectomy. A randomized controlled trial. Dr. Teoh Anthony
2009.343 Endovascular Repair of Thoracoabdominal Aortic dissection using the Cardiatis CTMS Stent Professor Yu Simon
2009.342 Weight Management Program for Controlling Weight Gain in Schizophrenic Patients: A Randomized Controlled Clinical Trial Ms. Wong Wai Ying Elsie
2009.340 Clinical bioequivalence study on two ampicillin formulations Professor Lee Hon-leung, Vincent
2009.339 Clinical bioequivalence study on two amisulpride formulations Professor Lee Hon-leung, Vincent
2009.338 Endovascular Treatment of Intracranial Aneurysms with Stenting (Pipeline Embolization Device) Professor Yu Simon
2009.333 The impact of 60 verse 120 shock wave per minute on treatment outcome, renal injury and patients Prof. Ng Chi Fai
2009.329 A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients with Aneurysmal Subarachnoid Hemorrhage Treated by Endovascular Coiling Professor Poon Wai-sang
2009.328 A Phase I, Randomised, multi-centre, open-label study to determine the pharmacokinetics and tolerability of cediranib (RECENTIN Associate Professor Brigette Ma
2009.326 Switching from Antipsychotics to Paliperidone ER in Obese Patients with Schizophrenia or Schizoaffective Disorder: The Effect on BMI and Metabolic Indices Prof. Lee Ho Ming, Edwin
2009.322 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control Prof. LAM Yat Yin
2009.309 An Open-label, Single-Arm, Phase 2 Study of Inotuzumab Ozogamicin Plus Rituximab in Subjects With Relapsed / Refractory CD22-Positive Diffuse Large B-Cell Lymphoma, Eligible for Autologous Stem Cell Transplantation Dr. WONG Raymond Siu Ming
2009.308 A Phase 2 Study of Inotuzumab Ozogamicin (CMC-544) in Subjects With Indolent Non-Hodgkin’s Lymphoma (NHL) That is Refractory to or has Relapsed After Rituximab and Chemotherapy or Radioimmunotherapy Dr. WONG Raymond Siu Ming
2009.300 A Randomized controlled clinical trial of balance training program with cutaneous electrical stimulation to improve balance performance in patients with sub-acute stroke Prof Woo Jean
2009.298 Australasian Resuscitation in Sepsis Evaluation Randomized Controlled Trial. A multi-centre, randomised controlled trial of early goal-directed therapy in patients presenting to the Emergency Department with severe sepsis in Australasia Prof Gomersall Charles
2009.297 Palliative Treatment for Unresectable Pancreatic Malignancy with High-Intensity-Focused-Ultrasound Prof. YU Simon
2009.295 High-Intensity-Focused-Ultrasound Treatment for Superficial Transitional Cell Carcinoma of Urinary Bladder Professor Yu Simon
2009.292 A randomized controlled trial comparing the treatment effects of patching versus acupuncture plus patching on amblyopia in patients of 7 to <13 years old Professor Lam Dennis Shun Chiu
2009.291 Safety and efficacy of using acupuncture as an adjunct to optical correction for amblyopia in children aged 3 to <7: A randomized controlled trial Professor Lam Dennis Shun Chiu
2009.290 A random-allocation graded dose-response study of intrathecal bupivacaine, levobupivacaine and ropivacaine for labor analgesia in nulliparous women Prof Ngan Kee Warwick
2009.289 Relieving insomnia in Chinese community-dwelling older people: the effects of cognitive-behavioral therapy Dr Doris Yu
2009.288 Early selective angiographic embolization to severely bleeding peptic ulcers after their initial endoscopic hemostasis – a randomized controlled trial (TAE Study 2) Prof. LAU James Yun Wong
2009.286 Effects of music therapy on oxygen saturation, heart rate and mean arterial pressure of premature infants receiving endotracheal suctioning: A pilot study. Mrs. Cheng Shuk Man
2009.275 A Phase I/II, Open-label, Multicentre Study to Assess the Safety & Tolerability, and Pharmacokinetics of AZD8055 in Asian Patients with Advanced Stage Hepatocellular Carcinoma (HCC) and with Mild or Moderate Hepatic Impairment Prof Brigette Ma
2009.274 A Phase III, multi-center, placebo-controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2 or 3 previous treatment regimens Prof. Mok Tony S. K.
2009.263 Effect of proton pump inhibitor on gastric emptying and satiety function in patients with functional dyspepsia Prof. WU Justin Che Yuen
2009.262 A 52 week randomized, controlled, open label, multicentre, multinational treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a basal-bolus regimen with insulin aspart as mealtime insulin Prof Wu Justin, Che-yuen
2009.261 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control Prof. TOMLINSON Brian
2009.258 Provision of Human Study on Interactions of Oseltamivir and Chinese Medicine Formulae Prof. Zuo Zhong
2009.256 Outcome of stage-specific early intervention for psychosis in Hong Kong: A randomized controlled study Dr Chung Dicky Wai Sau
2009.248 A randomized phase II study comparing acupuncture to acupuncture with moxibustion on reduction of chemotherapy-induced neutropenia Professor Mok Tony
2009.244 Influenza Resistance Information Study (IRIS) Prof Chan Paul
2009.234 A 17-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Of Pregabalin For The Treatment Of Chronic Central Neuropathic Pain After Spinal Cord Injury Associate Consultant Law Sheung Wai
2009.223 A Phase 2, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of FOLFIRI in Combination With AMG 479 or AMG 655 Versus FOLFIRI for the Second-line Treatment of KRAS-mutant Metastatic Colorectal Carcinoma Professor Ma Brigette
2009.222 A phase I dose escalation, multi-center, open-label study of HSP990 administered orally in adult patients with advanced solid malignancies Prof. Ma Brigette
2009.220 Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS) Professor Cheng Gregory
2009.218 A Multicenter, Randomized, Doubled-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA-CER) Professor Cheuk-Man YU
2009.217 Optimise CRT Professor Yu Cheuk-Man
2009.212 A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes Dr. Ozaki Risa
2009.211 A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes Dr Tsang Chiu Chi
2009.210 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control Dr Kong Alice Pik-Shan
2009.209 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono-or Dual Combination Oral Antihyperglycemic Therapy Dr. TSANG Chiu Chi

Page 240 of 263.